Subclinical diabetic neuropathy: A common complication in Saudi diabetics

Saudi Medical Journal

Volumn 21, Issue 5, 2000, Pages 433-437

  Akbar, Daad H ^a   Mira, Sirag A ^a   Zawawi, Taree H ^a   Malibary, Hussein M ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Diabetic neuropathy; Risk factors; Saudi diabetics; Subclinical; Symptomatic

Indexed keywords

AGE; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; DIABETES MELLITUS; DIABETIC NEUROPATHY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; METABOLISM; MIDDLE AGED; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; PREVALENCE; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RISK FACTOR; SAUDI ARABIA; SMOKING; TIME; UNIVERSITY HOSPITAL;

AGE DISTRIBUTION; AGE FACTORS; AGED; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETIC NEUROPATHIES; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; NEURAL CONDUCTION; NEUROLOGIC EXAMINATION; POPULATION SURVEILLANCE; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SAUDI ARABIA; SEVERITY OF ILLNESS INDEX; SMOKING; TIME FACTORS;

EID: 0034189820     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Ziegler D. Diagnosis, staging and epidemiology of diabetic peripheral neuropathy. Diabetes Nutr Metab 1994; 7: 342-348.
2. Pirart J. Diabetes mellitus and it's degenerative complications: A prospective study of 4.400 patients observed between 1947 and 1973. Diabetes Care 1978; 1: 168-188.
3. Young MJ, Boulton AJ. Macleod AF. Williams DR, Sonksen PH. Multi center study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinical population. Diabetologia 1993; 36: 150-154.
4. Navarro X, Kennedy WR, Aeppli D, Sutherland DER. Neuropathy and mortality in diabetes: Influence of pancreas transplantation. Muscle Nerve 1996; 19: 1009-1016.
5. Boyko EJ, Ahroni JH, Smith DG, Davignon D. Increased mortality associated with diabetic ulcer. Diabet Med 1996; 13: 967-972
6. The Diabetes Control and Complications Trial Research Group: The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 1995; 122: 561-568.
7. Porte D Jr, Graft RJ, Halter JB, Pfeifer MA, Halar E. Diabetic neuropathy and plasma glucose control. Am J Med 1981; 70: 195-200.
8. Diabetes mellitus: Report of a WHO Study Group. Tech Rep Ser 1985; 727: 1-113.
9. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994; 17: 1281-1289.
10. Kimura J. Principles of nerve conduction studies. In Electrodiagnosis in Diseases of Nerve and Muscle: Principles and practice. Kimura J, editor. Philadelphia: Davis: 1989; p. 83-104.
11. Apelqvist J, Ragnarson-Tennvall G, Persson U, Larsson J. Diabetic foot ulcers in a multidisciplinary setting: an economic analysis of primary healing and healing with amputation. J Intern Med 1994; 235: 463-471.
12. Moss SE, Klein BEK. The prevalence and incidence of lower extremity amputation in a diabetic population. Arch Intern Med 1992; 152: 610-616.
13. Humphrey LL, Palumbo PJ, Butters MA, Hallett JW Jr, Chu CP, O'Fallon WM, Ballard DJ. The contribution of non-insulin dependent diabetes to lower-extremity amputation in the community. Arch Intern Med 1994; 154: 885-892.
14. Ahroni JH, Boyko EJ, Davignon DR, Pecoraro RE. The health and functional status of veterans with diabetes. Diabetes Care 1994; 17: 318-321.
15. O'Hare JA, Abuaisha F, Geoghegan M. Prevalence and forms of neuropathic morbidity in 800 diabetics. Ir J Med Sci 1994; 163: 132-135.
16. Tesfaye S, Stevens LK, Stephenson JM. Fuller JH. Plater M Ionescu-Tirgoviste C et al. Prevalence of diabetic peripheral neuropathy and itís relation to glycemic control and potential risk factors: The EURODIAB IDDM Complications Study. Diabetologia 1996; 39: 1377-1384.
17. Fedele D, Comi G, Coscelli C, Cucinotta D, Feldman EL, Ghirlanda G et al. A multi center study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee. Diabetes Care 1997; 20: 836-43.
18. Sangiorgio L, Iemmolo R, Le-Moli R, Grasso G, Lunetta M. Diabetic neuropathy: Prevalence, concordance between clinical and electrophysiological testing and impact of risk factors. Pnminerva-Med 1997; 39: 1-5.
19. Grzelec H. Clinical and electroneurographic changes in the peripheral nervous system of patients with chronic insulin-dependent diabetes (IDDM). Ann Acad Med Stetin 1994; 40: 171-194.
20. Brown MR, Dyek PJ, McClean GE, Simma AA, Powell HC, Porte D. Central and peripheral nervous system complications. Diabetes 1982; 31 (Suppl I, Pt 2): 65-70.
21. Lamontage A, Buchthal F. Electrophysiological studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry. 1970; 33: 442-452.
22. Young RJ, Ewing DJ, Clarke BF. Nerve function and metabolic control in teenagediabetics. Diabetes 1983; 32: 142-147.
23. Bertora O, Valla P, Dezuanni E, Osio M, Mantica D. Bevilacqua M et al. Prevalence of sub clinical neuropathy in diabetic patients: assessment by study of conduction velocity distribution within motor and sensory nerve fibre. J Neurol 1998; 245: 81-86.
24. DCCT Research Group: The diabetes Control and Complication Trial (DCCT): design and methodologic considerations for the feasibility phase. Diabetes 1986; 35: 530-545.
25. Dyck PJ, Davies JL, Litchy WJ, O'Brien PC. Longitudinal assessment of diabetic polyneuropathy using a compsite score in the Rochester Diabetic Neuropathy Study cohort. Neurology 1995; 49: 229-239.
26. Hilson RM, Hockaday TDR, Newton DJ. Hyperglycemia is one correlate of deterioration in vibration sense during the 5 years after diagnosis of type 2 (non-insulin dependent) diabetes. Diabetologia 1984; 26: 122-126.
27. Maser RE, Steenkist AR, Dorman JS. Nielsen VK, Bass EB, Manjoo Q et al. Epidemiological correlate of diabetic neuropathy: Report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 1989; 38: 1456-1461.
28. Bild DE, Selby P, Browner WS, Braverman P, Braverman P, Showstack JA. Lower extremity amputation in people with diabetes: Epidemiology and prevention. Diabetes Care 1989; 12: 24-31.
29. Moss SE, Klein R, Klein BE. Long term incidence of lower-extremity amputations in a diabetic population. Arch Fam Med 1996; 5: 391-398.
30. Humphrey ARG, Dowse GK, Thomas K, Zimmer PZ. Diabetes and non-traumatic lower extremity amputations: Incidence, risk factors and prevention: 12-year follow up study in Nauru. Diabetes Care 1996; 19: 710-714.
31. Lehto S, Ronnemaa T, Pyorala K, Laakso M. Risk factors predicting lower extremity amputations inpatients with NIDDM. Diabetes Care 1996; 19: 607-612.
32. Edmonds ME. Blundel MP, Morris ME, Thomas EM, Cotton LT, Watkins PJ. Improved survival of the diabetic foot: The role of specialised foot clinic. Q J Med 1986; 232: 763-771.
33. Abbott CA, Vileikyte L, Williamson S, Carrington AL, Boulton AJ. Multi center study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care 1998; 21: 1071-1075.